ArticleFrontiers in pharmacology2025

Real-world patient outcomes with Blinatumomab and Inotuzumab in adult relapsed/refractory B-cell acute lymphoblastic leukemia: a retrospective analysis from two Romanian oncology centers.

Ion Antohe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.